HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR)
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $30.00 price target on the stock. VYGR has been the subject of a number of other reports. StockNews.com cut shares of Voyager Therapeutics from a […]
